Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorescein-aided glioblastoma surgery (phase II)
2015-003402-16Phase 2Terminated
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fluorescein in glioblastoma (GBM), sponsored by IRCCS San Matteo Foundation. Primary endpoint: Gross total resection rate. Started Nov 2020; status: terminated.
02
Drugs
fluorescein
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on 2015-003402-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003402-16.